TNFRSF10B and lung carcinoma: In TRAIL-resistant lung cancer cells, CNOT2 knockdown sensitized cells to TRAIL-mediated apoptosis by modulating SHP1-STAT3 signaling and activating death receptor 5 (DR5) through intracellular stress responses [22].